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Abstract
In  order  to  test  the  hypothesis  that  endogenous  opiates  are  at  least  partially  responsible  for 
hyperinsulinaemia  in  patients  with  polycystic  ovarian  disease  (PCOD),  the  effect  of  naloxone  (an 
opiate receptor blocker) on the insulin response to oral glucose load (OGTT) was studied in 20 women 
with PCOD and 17 control subjects at days 5-8 of their follicular phase. After fasting overnight for 
10-12 h, each woman received an i.v. bolus injection (2 mg) of naloxone or an equal volume of saline 
infusion followed by a constant infusion of naloxone or saline solution at a rate of 8 ml/h (1 mg/h of 
naloxone) for 5 h. OGTT (75 g) was performed 1 h after the bolus injection. The naloxone study was 
performed 48 h after the saline study. Naloxone did not modify the insulin response to OGTT in either 
group.  When  the  data  were  related  to  the  insulin  response,  in  PCOD hyperinsulinaemic  patients, 
naloxone significantly reduced (P less than 0.02) the insulin response to OGTT without any change in 
glycaemic response curves. In control and PCOD normoinsulinaemic patients, naloxone did not change 
significantly either the glycaemia or the insulin levels after OGTT. No change of gonadotrophin and 
steroid secretion was found in any patient receiving naloxone. In conclusion, endogenous opiates may 
play a significant role in hyperinsulinaemia in PCOD.
